EGFR and infection: However, EGFR inhibitors will also impair epithelial tissue regrowth necessary to restore respiratory barrier function after severe infections with IAV and other respiratory viruses associated with hyperactive EGFR signaling, such as respiratory syncytial virus (RSV) and SARS-CoV (Venkataraman et al., 2017; Kalinowski et al., 2018).